In addition, inhibition of DCLK1 kinase activity by DCLK1-IN-1 treatment reduced the PGE2 level in both plasma and tumor tissues in MC38 syngeneic mice (Figure 4H). This evidence concerns the gene DCLK1 and neoplasm.